Issues Unique to Pediatric Liver Transplantation

Clinics in Liver Disease

Volumn 11, Issue 2, 2007, Pages 323-335

  Kerkar, Nanda ^a   Emre, Sukru ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACICLOVIR; ALPHA TOCOPHEROL; AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; DEFEROXAMINE; GANCICLOVIR; IMMUNOGLOBULIN G ANTIBODY; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PARACETAMOL; PREDNISONE; PROSTAGLANDIN E1; RAPAMYCIN; RITUXIMAB; SELENIUM; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

AUTOIMMUNE HEPATITIS; BILE DUCT ATRESIA; COMBINATION CHEMOTHERAPY; DRUG DOSE REDUCTION; GRAFT REJECTION; HEMOCHROMATOSIS; HEPATITIS C; HUMAN; HYPEROXALURIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY POLYCYSTIC DISEASE; LABORATORY TEST; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FIBROSIS; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; ORGAN DONOR; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PEDIATRIC SURGERY; PORTOENTEROSTOMY; POSTOPERATIVE COMPLICATION; REVIEW; SCORING SYSTEM; SINGLE DRUG DOSE; SURGICAL TECHNIQUE; TISSUE PRESERVATION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VASCULAR TUMOR; VIRUS HEPATITIS;

ADULT; CHILD; HUMANS; IMMUNOSUPPRESSION; INFANT; LIVER DISEASES; LIVER TRANSPLANTATION; PATIENT COMPLIANCE; PATIENT SELECTION; TRANSPLANTS;

EID: 34250791742     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2007.04.001     Document Type: Review

References (37)

1. Rivera-Penera T., Moreno J., Skaff C., et al. Delayed encephalopathy in fulminant hepatic failure in the pediatric population and the role of liver transplantation. J Pediatr Gastroenterol Nutr 24 2 (1997) 128-134
2. Bucuvalas J., Yazigi N., and Squires Jr. R.H. Acute liver failure in children. Clin Liver Dis 10 1 (2006) 149-168 vii
3. Squires Jr. R.H., Shneider B.L., Bucuvalas J., et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 148 5 (2006) 652-658
4. Holme E., and Lindstedt S. Nontransplant treatment of tyrosinemia. Clin Liver Dis 4 4 (2000) 805-814
5. Dhawan A., and Mieli-Vergani G. Acute liver failure in neonates. Early Hum Dev 81 12 (2005) 1005-1010
6. Whitington P.F., and Malladi P. Neonatal hemochromatosis: is it an alloimmune disease?. J Pediatr Gastroenterol Nutr 40 5 (2005) 544-549
7. Rodrigues F., Kallas M., Nash R., et al. Neonatal hemochromatosis-medical treatment vs. transplantation: the king's experience. Liver Transpl 11 11 (2005) 1417-1424
8. Smith S.R., Shneider B.L., Magid M., et al. Minor salivary gland biopsy in neonatal hemochromatosis. Arch Otolaryngol Head Neck Surg 130 6 (2004) 760-763
9. Cochat P., Gaulier J.M., Koch Nogueira P.C., et al. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Eur J Pediatr 158 Suppl 2 (1999) S75-S80
10. Sokol R.J., and Treem W.R. Mitochondria and childhood liver diseases. J Pediatr Gastroenterol Nutr 28 1 (1999) 4-16
11. Wiesner R.H., McDiarmid S.V., Kamath P.S., et al. MELD and PELD: application of survival models to liver allocation. Liver Transpl 7 7 (2001) 567-580
12. McDiarmid S.V., Anand R., and Lindblad A.S. Development of a pediatric end-stage liver disease score to predict poor outcome in children awaiting liver transplantation. Transplantation 74 2 (2002) 173-181
13. Shneider B.L., Suchy F.J., and Emre S. National and regional analysis of exceptions to the Pediatric End-Stage Liver Disease scoring system (2003-2004). Liver Transpl 12 1 (2006) 40-45
14. Shneider B.L., Neimark E., Frankenberg T., et al. Critical analysis of the pediatric end-stage liver disease scoring system: a single center experience. Liver Transpl 11 7 (2005) 788-795
15. Starzl T.E., Kaulla K.N., Hermann G., et al. Homotransplantation of the liver in humans. Surg Gynecol Obstet 117 (1963) 659-676
16. Shaw Jr. B.W., Martin D.J., Marquez J.M., et al. Venous bypass in clinical liver transplantation. Ann Surg 200 4 (1984) 524-534
17. Tzakis A., Todo S., and Starzl T.E. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg 210 5 (1989) 649-652
18. Calne R.Y., and Williams R. Liver transplantation in man. I. Observations of technique and organization in five cases. Br Med J 4 (1968) 535-540
19. Eghtesad B., Kadry Z., and Fung J. Technical considerations in liver transplantation: what a hepatologist needs to know (and every surgeon should practice). Liver Transpl 11 8 (2005) 861-871
20. Farmer D.G., Shaked A., Olthoff K.M., et al. Evaluation, operative management, and outcome after liver transplantation in children with biliary atresia and situs inversus. Ann Surg 222 1 (1995) 47-50
21. Emre S. Living donor liver transplantation: a critical review. Transplant Proc 33 7-8 (2001) 3456-3457
22. Bonatti H., Muiesan P., Connelly S., et al. Hepatic transplantation in children under 3 months of age: a single centre's experience. J Pediatr Surg 32 3 (1997) 486-488
23. Emre S. Living-donor liver transplantation in children. Pediatr Transplant 6 1 (2002) 43-46
24. Emre S., Schwartz M.E., Shneider B., et al. Living related liver transplantation for acute liver failure in children. Liver Transpl Surg 5 3 (1999) 161-165
25. Trotter J.F., Adam R., Lo C.M., et al. Documented deaths of hepatic lobe donors for living donor liver transplantation. Liver Transpl 12 10 (2006) 1485-1488
26. Feng S., Goodrich N.P., Bragg-Gresham J.L., et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 6 4 (2006) 783-790
27. Jansen P.L., Hess F., Peters W.H., et al. Auxiliary liver transplantation in jaundiced rats with UDP-glucuronyltransferase deficiency and defective hepatobiliary transport. J Hepatol 8 2 (1989) 192-200
28. Rela M., Muiesan P., Vilca-Melendez H., et al. Auxiliary partial orthotopic liver transplantation for Crigler-Najjar syndrome type I. Ann Surg 229 4 (1999) 565-569
29. Girlanda R., Vilca-Melendez H., Srinivasan P., et al. Immunosuppression withdrawal after auxiliary liver transplantation for acute liver failure. Transplant Proc 37 4 (2005) 1720-1721
30. Stangou A.J., Heaton N.D., and Hawkins P.N. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 352 22 (2005) 2356
31. Kerkar N., Hadzic N., Davies E.T., et al. De-novo autoimmune hepatitis after liver transplantation. Lancet 351 9100 (1998) 409-413
32. Kerkar N., Dugan C., Rumbo C., et al. Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant 5 5 (2005) 1085-1089
33. Shemesh E. Non-adherence to medications following pediatric liver transplantation. Pediatr Transplant 8 6 (2004) 600-605
34. Shemesh E., Shneider B.L., Savitzky J.K., et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 113 4 (2004) 825-832
35. Lurie S., Shemesh E., Sheiner P.A., et al. Non-adherence in pediatric liver transplant recipients-an assessment of risk factors and natural history. Pediatr Transplant 4 3 (2000) 200-206
36. Shemesh E., Lurie S., Stuber M.L., et al. A pilot study of posttraumatic stress and nonadherence in pediatric liver transplant recipients. Pediatrics 105 2 (2000) E29
37. Emre S. Posttraumatic stress disorder in posttransplant children: creating a clinical program to address their needs. CNS Spectr 11 2 (2006) 118 20-6